Investing Ideas
/
U.S. Pharmaceuticals & Biotech Sustainable Track Record

U.S. Pharmaceuticals & Biotech Sustainable Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

7 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MEDP Medpace Holdings	US$343.02	-0.6%	17.6%	US$10.7b	US$343.83	PE29.1x	E11.2%	n/a
CPRX Catalyst Pharmaceuticals	US$23.96	4.8%	66.4%	US$2.7b	US$32.75	PE20x	E16.7%	n/a
HALO Halozyme Therapeutics	US$55.83	1.0%	64.9%	US$7.1b	US$64.75	PE18.1x	E17.3%	n/a
PBYI Puma Biotechnology	US$3.07	4.1%	-34.7%	US$148.7m	US$4.33	PE6.5x	E-47.6%	n/a
ETST Earth Science Tech	US$0.22	15.8%	214.3%	US$65.1m	n/a	PE28.6x	n/a	n/a
MDXG MiMedx Group	US$9.05	0.7%	16.9%	US$1.3b	US$13.40	PE16.8x	E-1.9%	n/a
AMPH Amphastar Pharmaceuticals	US$36.42	0.8%	-31.7%	US$1.8b	US$56.40	PE11.1x	E5.8%	n/a

Page 1 of 1